0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$175.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
Cartalax (50mg) is manufactured to meet strict purity standards. Peptide purity refers to the proportion of the intended molecular structure present in the batch. Analytical verification confirms that each sample meets defined research specifications.
Cartalax (50mg) maintains consistent structural integrity across all batches. Structural consistency ensures reproducibility in laboratory workflows. Each batch is produced under monitored conditions to maintain predictable behavior during experimentation.
The peptide is packaged in standardized units suitable for research documentation. Pack size and unit labeling facilitate organized tracking and integration into research peptide supply systems.
Cartalax (50mg) is of scientific interest for its short peptide fragments. Peptide fragments are small chains of amino acids, which are organic molecules forming the building blocks of proteins.
Researchers explore these fragments to study structural behavior under controlled conditions. Research with Cartalax (50mg) is strictly non-clinical. It is not intended for human or veterinary use, prescription, or health interventions.
Cartalax (50mg) has been investigated in research settings to evaluate molecular stability and fragment interactions. Investigated in research settings means examined in controlled laboratory experiments without implying any outcome or benefit.
Some studies may focus on structural interactions or biochemical properties of short peptide sequences. Laboratory researchers analyze these interactions to gather experimental data, not to infer therapeutic effects.
Cartalax (50mg) is intended for laboratory handling only. Standard laboratory safety protocols should be followed.
Store Cartalax (50mg) in a cool, dry environment to maintain peptide stability. Proper storage ensures consistent results across research experiments.
This peptide is not a prescription product. It is not distributed through pharmacies and does not require a doctor’s oversight.
Each batch of Cartalax (50mg) undergoes quality control testing. Purity verification is conducted using high-performance liquid chromatography (HPLC). HPLC separates and quantifies molecular components to confirm the intended structure.
Batch consistency is confirmed through analytical procedures to ensure reproducible results. Quality control testing Cartalax (50mg) maintains high research-grade standards.
All units include labeling for pack size, batch number, and analytical documentation for traceability within research peptide supply systems.
Cartalax (50mg) is a synthetic peptide fragment. Peptides are short chains of amino acids, which are small organic compounds forming proteins.
The sequence and structure of Cartalax (50mg) are verified through mass spectrometry. Mass spectrometry is a laboratory technique that measures molecular weight and confirms structural composition.
This peptide fragment is engineered for stability and high peptide purity. No additional sugars or excipients are included, supporting analytical reliability.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade synthetic dual-agonist peptide formulated in higher-quantity 15mg format for extended dual-receptor pathway studies and institutional peptide research in controlled laboratory environments.
Research-grade synthetic peptide formulated in mid-range 10mg quantity for cellular migration studies and peptide actin-binding research in controlled laboratory environments.
Explore GHK-CU BPC-157 Tb-500 KPV Klow Blend, Novera's most advanced peptide blend. This superior four-peptide formula delivers unmatched benefits for skin and tissue repair, inflammatory balance, and rapid recovery.
Research-grade dual-peptide blend combining short-acting synthetic peptides for flexible laboratory research protocols.
